Literature DB >> 16715583

HIV-1 CRF07_BC infections, injecting drug users, Taiwan.

Yi-Ming Arthur Chen, Yu-Ching Lan, Shu-Fen Lai, Jyh-Yuan Yang, Su-Fen Tsai, Steve Hsu-Sung Kuo.   

Abstract

Entities:  

Mesh:

Year:  2006        PMID: 16715583      PMCID: PMC3294689          DOI: 10.3201/eid1204.050762

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


× No keyword cloud information.
To the Editor: To date, Taiwan's human immunodeficiency virus type 1 (HIV-1) epidemic has primarily spread via sexual contact. The subtype B and circulating recombinant form (CRF) 01_AE account for >95% of all infections (). However, since 2003 Taiwan has experienced a major outbreak of CRF07_BC among injecting drug users (IDUs). The first wave of HIV-1 infections in Taiwan can be traced to the early 1980s, when a group of hemophilia patients received imported HIV-1-contaminated antihemophilia medications. By the time these medications had been replaced by heat-treated factor VIII concentrates, at least 53 patients had contracted HIV-1 infections (). According to Taiwan's Center for Disease Control (CDC), HIV infections have been diagnosed in 9,229 persons (including 523 foreigners) as of July 31, 2005 (). The number of persons living with HIV-1/AIDS has increased rapidly in the past few years, with a 77% increase in 2004, compared to 11% in 2003 (Table). According to the results of a risk factor analysis of people living with HIV-1/AIDS reported to the Taiwan CDC, the proportion of IDUs increased from 1.7% (13/773) in 2002 to 8.1% (70/861) in 2003 to 30.3% (462/1,521) in 2004 (Table). The Taiwan CDC received reports of 1,241 IDUs diagnosed with HIV-1 infections from January 1 to July 31, 2005; these account for >75% of all reported HIV-1 infections in 2005 (). The evidence points to an explosive epidemic of HIV-1 infections among IDUs in Taiwan since 2003, with no indication of a slowdown.
Table

Annual number of HIV/AIDS cases reported to Taiwan Center for Disease Control, classified by risk group

Risk factorsNo. case by year
19941995199619971998199920002001200220032004
HIV+1742282773504014795356547738591513
AIDS6398159135152179179161178227254
Heterosexuals85109134154189214235275310251244
Homosexuals467096137141178223287335341339
Bisexuals2741374759706164795154
Hemophiliacs11210000000
Injection drug users666531741370462
Blood recipients11011030002
Vertical transmission00000610012
Unknown802581052436145410
Total1742282773504014795346547738591513
Taiwan has ≈60,000 IDUs (). According to the Republic of China Ministry of Justice, the number of incarcerated drug offenders increased from 5,988 in 2003 to 9,303 in 2004; the rate of HIV-1 seropositive inmates increased from 13.3/100,000 in 2002 to 56.8/100,000 in 2004 (Y-M. Wu, Ministry of Justice, pers. comm.). Since all inmates are routinely tested for HIV-1 in detention centers, and all infected inmates are separated from HIV-1-seronegative inmates, the potential of HIV-1 transmission in prisons is remote. We therefore suggest that the Taiwanese IDU population and its HIV-1 seropositive rate have both increased rapidly in the past few years. To identify the primary HIV-1 strains in the current epidemic, we collected blood specimens from HIV-1-infected inmates in 3 detention centers (1 each located in the northern, central and southern regions of Taiwan). HIV-1 subtypes were determined by polymerase chain reaction, DNA sequencing, and phylogenetic analyses of pol or env genes. Our results indicate that 145 (96%) of 151 IDUs were infected with CRF07_BC and 6 (4%) were infected with subtype B; 97% of the CRF07_BC cases were diagnosed in 2003 or 2004. According to our phylogenetic analysis of the env gene, the Taiwanese CRF07_BC strains clustered with CRF07_BC strains drawn from IDUs in China (Figure).
Figure

Phylogenetic analyses of 7 HIV-1 isolates identified in Taiwan. TW-7496, TW-D16, TW-D17, and TW-D22 were collected from detention center inmates; TW-9541 and TW-9539 were collected from a blood donor and 1 of his donation recipients. This neighbor-joining tree was created from 100 bootstrap samples of aligned env sequences corresponding to the 7077–7340 nucleotide residues of HIV-1-HXB2 from different isolates. Bootstrap values are shown on branch nodes. Reference isolates from the GenBank HIV database are indicated by subtype.

Phylogenetic analyses of 7 HIV-1 isolates identified in Taiwan. TW-7496, TW-D16, TW-D17, and TW-D22 were collected from detention center inmates; TW-9541 and TW-9539 were collected from a blood donor and 1 of his donation recipients. This neighbor-joining tree was created from 100 bootstrap samples of aligned env sequences corresponding to the 7077–7340 nucleotide residues of HIV-1-HXB2 from different isolates. Bootstrap values are shown on branch nodes. Reference isolates from the GenBank HIV database are indicated by subtype. CRF07_BC is a recombinant of the B´ and C subtypes. Several studies have suggested that CRF07_BC originated in China's Yunnan Province, with subtype B´ from Thailand mixing with subtype C from India before moving northwestward to Xinjiang Province along a major Chinese heroin trafficking route (–). To our knowledge, this is the first report of a large group of IDUs in northeastern Asia having CRF07_BC infections. It may have followed another drug trafficking route from Yunnan Province to southeast China, moving through Guangxi Province and Hong Kong to Taiwan (–). In a bid to combat skyrocketing HIV/AIDS infection rates among IDUs, the Taiwan CDC has proposed a 5-year harm reduction program to the Republic of China Executive Yuan.
  7 in total

1.  On-going generation of multiple forms of HIV-1 intersubtype recombinants in the Yunnan Province of China.

Authors:  Rongge Yang; Xueshan Xia; Shigeru Kusagawa; Chiyu Zhang; Kunlong Ben; Yutaka Takebe
Journal:  AIDS       Date:  2002-07-05       Impact factor: 4.177

2.  Asia and Africa: on different trajectories?

Authors:  Jon Cohen
Journal:  Science       Date:  2004-06-25       Impact factor: 47.728

3.  Temporal trends and molecular epidemiology of HIV-1 infection in Taiwan from 1988 to 1998.

Authors:  Y M Chen; K L Huang; I Jen; S C Chen; Y C Liu; Y C Chuang; J C Wong; J J Tsai; Y C Lan
Journal:  J Acquir Immune Defic Syndr       Date:  2001-03-01       Impact factor: 3.731

4.  Molecular characterization of human immunodeficiency virus type 1 and hepatitis C virus in paid blood donors and injection drug users in china.

Authors:  Linqi Zhang; Zhiwei Chen; Yunzhen Cao; Jian Yu; Guanghan Li; Wenjie Yu; Ning Yin; Shan Mei; Li Li; Peter Balfe; Tian He; Lei Ba; Fengwen Zhang; His-Hsun Lin; Man-Fung Yuen; Ching-Lung Lai; David D Ho
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

5.  Characterization of a virtually full-length human immunodeficiency virus type 1 genome of a prevalent intersubtype (C/B') recombinant strain in China.

Authors:  L Su; M Graf; Y Zhang; H von Briesen; H Xing; J Köstler; H Melzl; H Wolf; Y Shao; R Wagner
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

6.  A recent outbreak of human immunodeficiency virus type 1 infection in southern China was initiated by two highly homogeneous, geographically separated strains, circulating recombinant form AE and a novel BC recombinant.

Authors:  S Piyasirisilp; F E McCutchan; J K Carr; E Sanders-Buell; W Liu; J Chen; R Wagner; H Wolf; Y Shao; S Lai; C Beyrer; X F Yu
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

7.  The lack of epidemiological link between the HIV type 1 infections in Hong Kong and Mainland China.

Authors:  W L Lim; H Xing; K H Wong; M C Wong; Y M Shao; M H Ng; S S Lee
Journal:  AIDS Res Hum Retroviruses       Date:  2004-03       Impact factor: 2.205

  7 in total
  12 in total

1.  Near full-length genomic characterization of a HIV type 1 BC recombinant strain from Manipur, India.

Authors:  Roni Sarkar; Kamalesh Sarkar; N Brajachand Singh; Y Manihar Singh; Sekhar Chakrabarti
Journal:  Virus Genes       Date:  2012-06-19       Impact factor: 2.332

2.  First Appearance of HIV-1 CRF07_BC and CRF08_BC Outside China.

Authors:  Xin Chen; Mei Ye; Wei Pang; Davey M Smith; Chiyu Zhang; Yong-Tang Zheng
Journal:  AIDS Res Hum Retroviruses       Date:  2016-08-16       Impact factor: 2.205

3.  Molecular epidemiology of hepatitis D virus infection among injecting drug users with and without human immunodeficiency virus infection in Taiwan.

Authors:  Sui-Yuan Chang; Chia-Ling Yang; Wei-Shin Ko; Wen-Chun Liu; Chi-Ying Lin; Cheng-Hsin Wu; Yi-Chin Su; Shu-Fang Chang; Mao-Yuan Chen; Wang-Huei Sheng; Chien-Ching Hung; Shan-Chwen Chang
Journal:  J Clin Microbiol       Date:  2010-12-29       Impact factor: 5.948

4.  Molecular epidemiological identification of Neisseria gonorrhoeae clonal clusters with distinct susceptibility profiles associated with specific groups at high risk of contracting human immunodeficiency virus and syphilis.

Authors:  Wing-Wai Wong; Chung-Ter Huang; Lan-Hui Li; Chien-Chou Chiang; Bor-Dong Chen; Shu-Ying Li
Journal:  J Clin Microbiol       Date:  2008-10-08       Impact factor: 5.948

5.  A Smartphone Application Supporting Recovery from Heroin Addiction: Perspectives of Patients and Providers in China, Taiwan, and the USA.

Authors:  Marya Schulte; Di Liang; Fei Wu; Yu-Ching Lan; Wening Tsay; Jiang Du; Min Zhao; Xu Li; Yih-Ing Hser
Journal:  J Neuroimmune Pharmacol       Date:  2016-02-04       Impact factor: 4.147

Review 6.  Changing patterns of HIV epidemic in 30 years in East Asia.

Authors:  S Pilar Suguimoto; Teeranee Techasrivichien; Patou Masika Musumari; Christina El-saaidi; Bhekumusa Wellington Lukhele; Masako Ono-Kihara; Masahiro Kihara
Journal:  Curr HIV/AIDS Rep       Date:  2014-06       Impact factor: 5.071

7.  Molecular Epidemiology of HIV-1 Infection among Men who Have Sex with Men in Taiwan in 2012.

Authors:  Szu-Wei Huang; Sheng-Fan Wang; Ángel E Cowó; Marcelo Chen; Yu-Ting Lin; Chun-Po Hung; Yi-Hsien Chen; Jyh-Yuan Yang; Hung-Jen Tang; Yi-Ming Arthur Chen
Journal:  PLoS One       Date:  2015-06-03       Impact factor: 3.240

8.  Patients infected with CRF07_BC have significantly lower viral loads than patients with HIV-1 subtype B: mechanism and impact on disease progression.

Authors:  Szu-Wei Huang; Sheng-Fan Wang; Yu-Ting Lin; Chia-Hung Yen; Chih-Hao Lee; Wing-Wai Wong; Hung-Chin Tsai; Chia-Jui Yang; Bor-Shen Hu; Yu-Huei Lin; Chin-Tien Wang; Jaang-Jiun Wang; Zixin Hu; Daniel R Kuritzkes; Yen-Hsu Chen; Yi-Ming Arthur Chen
Journal:  PLoS One       Date:  2014-12-11       Impact factor: 3.240

9.  Characterization of the Drug Resistance Profiles of Patients Infected with CRF07_BC Using Phenotypic Assay and Ultra-Deep Pyrosequencing.

Authors:  Szu-Wei Huang; Wei-You Li; Wen-Hung Wang; Yu-Ting Lin; Chih-Hung Chou; Marcelo Chen; Hsien-Da Huang; Yen-Hsu Chen; Po-Liang Lu; Sheng-Fan Wang; Shinichi Oka; Yi-Ming Arthur Chen
Journal:  PLoS One       Date:  2017-01-20       Impact factor: 3.240

10.  Ascertaining the 2004-2006 HIV type 1 CRF07_BC outbreak among injecting drug users in Taiwan.

Authors:  Ying-Hen Hsieh
Journal:  Int J Infect Dis       Date:  2013-02-12       Impact factor: 3.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.